CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 47 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29,575 | -45.7% | 19,330 | -40.4% | 0.00% | – |
| Q1 2024 | $54,482 | -7.9% | 32,430 | -1.8% | 0.00% | – |
| Q4 2023 | $59,180 | -5.8% | 33,030 | -0.6% | 0.00% | – |
| Q3 2023 | $62,805 | +28.6% | 33,230 | 0.0% | 0.00% | – |
| Q2 2023 | $48,848 | -25.1% | 33,230 | -0.6% | 0.00% | – |
| Q1 2023 | $65,189 | -24.6% | 33,430 | -13.0% | 0.00% | – |
| Q4 2022 | $86,468 | -20.7% | 38,430 | -15.0% | 0.00% | – |
| Q3 2022 | $109,000 | +1.9% | 45,215 | -12.2% | 0.00% | – |
| Q2 2022 | $107,000 | -57.4% | 51,502 | -42.2% | 0.00% | -100.0% |
| Q1 2022 | $251,000 | -35.1% | 89,083 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $387,000 | +96.4% | 82,920 | +115.5% | 0.00% | 0.0% |
| Q4 2013 | $197,000 | +82.4% | 38,485 | +61.0% | 0.00% | 0.0% |
| Q3 2013 | $108,000 | -16.3% | 23,900 | -5.2% | 0.00% | 0.0% |
| Q2 2013 | $129,000 | – | 25,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $59,000 | 0.04% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 176,185 | $472,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,987 | $435,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 162,217 | $429,000 | 0.00% |
| Renaissance Technologies | 664,564 | $1,781,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $8,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 696,654 | $1,881,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 16,246 | $44,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,614 | $13,000 | 0.00% |
| MORGAN STANLEY | 3,172 | $8,000 | 0.00% |